Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

Enertopia Provides Burlington MMPR Update

Posted by AGORACOM-JC at 8:23 AM on Tuesday, December 9th, 2014

VANCOUVER, BC / December 9, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce that Health Canada has advised the Company that the Burlington, Ontario application has advanced to the Enhanced Screening Stage of the application process.

The company is pleased to advise shareholders that its license application with joint venture partner, Lexaria Corp (LXRP), submitted for licensed producer in July 2014 is now at the Enhanced Screening process. Ontario Operations Manager Mr. Donald Shaxon is the responsible person in charge of the Burlington JV.

The Burlington Joint Venture with Lexaria Corp has applied to produce 10,000kg of Medical Marihuana per year under its Licensed Producer application. Enertopia has 51% interest in the joint venture and Lexaria Corp 49% as disclosed on April 9, 2014 in Enertopia’s press release #201424 and press release #201439.

The Burlington JV has requested a Ready to build letter from Health Canada once the application has made it through step 4 of the approval process.

For those not familiar with the Health Canada process for becoming a licensed producer, below are the levels to be reached through the application process. Note there are no specific process times for each step:

Step 1: Preliminary Screening (Completed)
Step 2: Enhanced Screening (Underway)
Step 3: Security Clearance
Step 4: Review
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Step 7: Licensing

The Joint Venture (JV) has been active in the local community and has received very good community and media support. The JV also met with the local policing authority and upon licensing by Health Canada we have proposed that the local police could conduct security and swat team training at the facility. We are very pleased to be working closely with law enforcement and look forward to their insights in preventative and proactive security measures.

On November 24, 2014 Health Canada updated the number of Licensed Producers to grow and sell Marijuana to 14 and the number of Licensed Producers to grow Marijuana at 8 for a current total of 22 Licensed Producers in Canada.

“Enertopia looks forward to the next steps in the application process and receiving a letter to build in 2015. In 2015 Enertopia we will be launching education and wellness seminars to help educate the public and medical community on the responsible and educated uses of Medical Marijuana” Stated President / CEO Robert McAllister.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential licensing and financing of its medical marihuana projects, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Burlington Joint Venture will obtain a license under MMPR and or that the Company will receive a letter to build in 2015 or be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Provides Burlington MMPR Update

Lexaria Updates Burlington License Application

Posted by AGORACOM-JC at 8:10 AM on Tuesday, December 9th, 2014

Kelowna, British Columbia — (December 9, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce progress on the Burlington, Ontario MMPR license application.

Health Canada has advised our joint venture partner Enertopia Corp (ENRT) that the Burlington, Ontario application has advanced to the Enhanced Screening Stage of the application process. The Burlington Joint Venture with Enertopia Corp originally applied in July 2014 to produce 10,000kg of Medical Marihuana per year under its Licensed Producer application. Enertopia has 51% interest in the joint venture and Lexaria Corp 49% as earlier released.

Health Canada has noted the following steps in processing an application. Note there are no specific process times for each step:

Step 1: Preliminary Screening (Completed)
Step 2: Enhanced Screening (Underway)
Step 3: Security Clearance
Step 4: Review
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Step 7: Licensing

The current application is thorough and has been considerably improved by improvements made during the Preliminary Screening process, which has now been completed. The Burlington JV has requested a Ready To Build letter from Health Canada once the application has completed step 4 of the approval process.

The Joint Venture (JV) has been active in the local community and has received very good community and media support. The JV also met with the local policing authority and upon licensing by Health Canada we have proposed that the local police could conduct security and swat team training at the facility. We are very pleased to be working closely with law enforcement and look forward to their insights in preventative and proactive security measures.

Lexaria thanks its managers and its consultants for their dedication and hard work in advancing the license application to date.

On November 24, 2014 Health Canada updated the number of Licensed Producers to sell Marijuana to 14 and the number of Licensed Producers to grow Marijuana at 8 for a current total of 22 Licensed Producers in Canada.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for opportunities that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana or alternative health businesses will provide any benefit to Lexaria. The Company makes no human health claims related to cannabinoids derived from any source.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Updates Burlington License Application

Robix Signs Exclusive Deal With Rayco to Manufacture COV

Posted by AGORACOM-JC at 12:35 PM on Monday, December 8th, 2014

Deal Contemplates Marine and Oil Sand Tailings Applications

LETHBRIDGE, ALBERTA–(Dec. 8, 2014) – Robix Alternative Fuels Inc. (“Robix” or the “Corporation”) (CSE:RZX)(FRANKFURT:R0X) announced today that it has signed an exclusive manufacturing agreement with Rayco Steel Ltd, of Sparwood, British Columbia, to manufacture the Clean Ocean Vessel (COV). The manufacturing agreement covers the current design of the COV which is targeted toward oil spill containment and recovery in marine applications. In addition, Rayco also has exclusive rights to manufacture subsequent COV designs including non-marine applications such as waste water streams from the oil sands and oil production environments generally. Finally, Rayco will provide Quality Assurance Quality Control to Robix on all COV manufacturing even in instances where the COV is manufactured off-site. The agreement is in effect until terminated by Rayco giving Robix not less than 60 days prior written notice. Pricing will be determined between parties at the time of the order.

“Rayco’s work to date on our first commercial COV has been excellent and that quality workmanship has given me confidence in selecting them as our exclusive COV manufacturer,” commented Nathan Hansen, President and CEO of Robix. “They have project managed the construction, worked to a tight budget and been instrumental in working with marine engineers and architect group as well as Transport Canada to facilitate design improvements to the COV which will make this iteration, a product that meets 21st century specifications.” Mr. Hansen continued, “Our business model has always been to be the owner and marketer of leading edge technology in this space. By contracting the COV construction to Rayco, we are not incurring extensive capex costs from purchasing manufacturing facilities. As a result we are managing our share structure which is small compared to our peers at a similar stage of development. Our goal is to be selling COV products in the first half of 2015.”

In addition, Robix has been examining the use of the COV design in non-marine applications including tailings ponds in the Alberta Oil Sands projects. A tailings pond is an engineered dam and dyke system that is used as a settling basin/storage container for the mixture of water, sand, clay and residual oil that is left over after oil sands processing. Management believes the COV could be used in these environments to contain and recover oil from the tailings ponds.

Mr. Hansen continued, “In tandem to building the first commercial COV, we’ve been working with Rayco on testing the principles of the COV design on non-marine applications. These include waste water streams from oil production and represents a new potentially lucrative revenue stream for Robix. The COV is a very versatile design which can be applied to a number of applications. I look forward to exploring this avenue further, but our first priority is to get the COV into the water to test its performance in open seas and prove sea worthiness. We are slightly behind schedule and due to the December holiday season will likely be ready to launch the COV in January.”

About Rayco

Rayco operates a 17,000 sq. ft. state-of-the-art fabrication shop in Sparwood, BC and employs 68 qualified professionals. Rayco has been supplying mines and industry with quality steel fabrication and QC work since 1980. Certified to division 2.1 with the C.W.B, Rayco provides structural steel fabrication, heavy plate work, maintenance and equipment upgrades. In addition, they are qualified supplier to Teck Coal Ltd. sites.

About Robix:

The Corporation is an “industrial products/technology” company, offering to investors a unique opportunity to participate in a leading company in the business of ownership of patents, and their development from commercialization to worldwide expansion through various business arrangements. Robix owns a Clean Ocean Vessel (“COV”) patent, which is an oil spill recovery vessel design with the capability to recover oil in rough and debris laden sea conditions. Robix has recognized a worldwide market opportunity for effective containment, recovery and disposal equipment, particularly in the oil spill protection industry, and it proposes to develop a business model as a service provider, and/or equipment provider under licensing agreements with other industry participants, wherein Robix will use its COV patented design solution.

No stock exchange or any securities regulatory body has reviewed the contents of this news release.

This news release may contain certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the company’s disclosure documents on the SEDAR website at www.sedar.com. The company does not undertake to update any forward-looking information except in accordance with applicable securities laws.

Robix Alternative Fuels Inc.
Nathan Hansen
President & CEO
250-683-8957
[email protected]

Robix Alternative Fuels Inc.
Robin Ray
Chief Financial Officer
403-327-3094
[email protected]

Tags: , , , , ,
Posted in All Recent Posts, Robix Alternative Fuels | Comments Off on Robix Signs Exclusive Deal With Rayco to Manufacture COV

Newnote Financial Announces Launch of Puretradeâ„¢ Crypto-Currency Exchange

Posted by AGORACOM-JC at 9:07 AM on Tuesday, December 2nd, 2014

Vancouver, British Columbia – Newnote Financial Corp. (the “Company”), (CSE: NEU; OTCQB: NWWTF; FSE: 1W4) is pleased to announce the live public beta launch of our proprietary crypto-currency exchange, Puretrade. Puretrade enables users to trade Bitcoin, as well as other crypto-currency coin-pairings such as Bitcoin for Litecoin and vice-versa.

During the course of 2014, Newnote has been developing and testing its flagship web-based and mobile service Puretrade Exchange. Utilizing the services of our alliance partners Coinpayments.net, Net-Cents and Primebit Japan, Puretrade enables users to deposit and withdraw funds via Net-Cents, list new coin-pairings and provide liquidity for Coinpayments.net’s 8,000 strong merchant client base in addition to offering the Japanese market digital currency trading and arbitrage opportunities through our partner Primebit.

Newnote intends to continue attracting new alliance partners in various countries where there is clearly a need for an exchange. Alliance partners utilize the Puretrade platform for the backend while using their existing financial institutions within their region for electronic fund transfers to and from client accounts. Each new partner will contribute to the liquidity of Bitcoin and other digital currencies traded on Puretrade.

In addition, Newnote’s development team has built out the Puretrade API to enable outside developers to seamlessly integrate third-party applications into the Puretrade platform. Typical applications may include Automated Banking Machines (ABM), high-frequency trading bots, mobile payment processing devices and iPhone/Android apps. API specification documentation is available on the Puretrade.ca website.

CEO and President Paul Dickson states: “This is a very significant milestone for Newnote, as Puretrade enables our organization to execute our previously announced plans with our partners. Just as significantly this will allow Newnote to develop new business relationships with other crypto-companies requiring a platform to buy and sell crypto-currencies. I’m personally thrilled with the possibilities the Puretrade API will offer developers and the creative applications they will come up with.“

The Puretrade Crypto-Currency Exchange can be accessed at www.puretrade.ca

About Newnote Financial Corp.

Newnote Financial Corp. is pioneering innovative crypto-currency and Bitcoin related software products and services geared at the growing business segment of this bourgeoning market. Newnote has positioned itself to be a leading contender in delivering opportunities to startup businesses world-wide and continues to create new opportunities for its clients and its shareholders. Newnote has a clear vision on the direction in which this new and unique business is headed and is continually adjusting and adopting new business practices in both technology and the policies & procedures required by banks and securities regulators.

Newnote Financial Contact Information

Paul Dickson

President, CEO & Director

Newnote Financial Corp.

CSE: NEU; OTCQB: NWWTF; FSE: 1W4

Suite 709-700 West Pender Street

Vancouver, BC V6C 1G8

direct: 604-229-0480

fax: 604-685-3833

web: www.newnote.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of Newnote Financial Corp. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

Tags: , , , , ,
Posted in Newnote Financial Corp. | Comments Off on Newnote Financial Announces Launch of Puretradeâ„¢ Crypto-Currency Exchange

Newnote Financial Announces Closing of Non-Brokered Financing

Posted by AGORACOM-JC at 4:20 PM on Monday, December 1st, 2014

Vancouver, British Columbia – Newnote Financial Corp. (the “Company”), (CSE: NEU; OTCQB: NWWTF; FSE: 1W4) is pleased to announce that it has closed its previously announced non-brokered private placement (the offering). Unit is comprised of one common share (“Common Share”) in the capital of the Issuer and one common share purchase warrant (“Warrant”) where each whole Warrant entitles the holder to purchase one additional common share (“Warrant Share”) at an exercise price of $0.20 per Warrant Share until 4:00 p.m. (Vancouver time) on the first business day after the date that is one year from the closing date of the offering of the Units subject to accelerated expiry where if at any time after the closing date of the offering of the Units the closing sales price of the Common Shares (or the closing bid, if no sales were reported on a trading day) as quoted on the Canadian Securities Exchange (or such other stock exchange, quotation system or market on which the Common Shares are listed and where a majority of the trading volume of the Common Shares occurs) is $0.30 or higher for a period of 10 consecutive trading days, then the Company may, within five days of such event, provide notice by way of press release to the holder of the Warrants of the early expiry of the Warrants, and thereafter the Warrants shall expire on that date that is 30 days from the date that such notice is given.

About Newnote Financial Corp.

Newnote Financial Corp. is pioneering innovative crypto-currency and Bitcoin related software products and services geared at the growing business segment of this bourgeoning market. Newnote has positioned itself to be a leading contender in delivering opportunities to startup businesses world-wide and continues to create new opportunities for its clients and its shareholders. Newnote has a clear vision on the direction in which this new and unique business is headed and is continually adjusting and adopting new business practices in both technology and the policies & procedures required by banks and securities regulators.

Newnote Financial Contact Information

Paul Dickson

President, CEO & Director

Newnote Financial Corp.

CSE: NEU; OTCQB: NWWTF; FSE: 1W4

Suite 709-700 West Pender Street

Vancouver, BC V6C 1G8

direct: 604-229-0480

fax: 604-685-3833

web: www.newnote.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of Newnote Financial Corp. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/newnote12012014.pdf

Tags: , , , , ,
Posted in Newnote Financial Corp. | Comments Off on Newnote Financial Announces Closing of Non-Brokered Financing

Lexaria Enters Agreement to Sell Belmont Lake Oil Assets

Posted by AGORACOM-JC at 8:09 AM on Monday, December 1st, 2014

Kelowna, British Columbia–(December 1, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it has entered an agreement to sell all its Belmont Lake oil assets in an all-cash transaction of $1.4 million to Cloudstream Belmont Lake, LP, of Houston Texas. The transaction is in the process of closing.

Lexaria is using the proceeds of the sale to retire all corporate debt, and to further pursue its entry into legal medical marijuana in Canada, and into Cannabidiol-fortified products in the USA, in those jurisdictions where it is legal to do so. Lexaria will be debt-free for the first time since 2007 and will not need to make monthly interest or principal payments for the first time in roughly 7 years.

“It was not easy to sell our minority interests in the oilfield in the environment of dropping oil prices this year,” said Chris Bunka, CEO of Lexaria. “This lump-sum cash infusion enables us to execute our business plan in the health and wellness sectors more aggressively than we were otherwise able.”

Lexaria has been in discussions with a number of interested parties over a period of several months, as it worked to obtain the best terms and conditions possible in the oil field sale for its shareholders, and is confident it has obtained the best price possible in the current environment.

Lexaria has refined its business model in order to be as active as possible within the confines of presently legal CBD-based industry sectors, and the sale of the Belmont Lake Oil Field significantly accelerates our ability to pursue this market as aggressively as possible. The Company believes its potential growth rate in the CBD sector exceeds that which was possible at the Belmont Lake Oil Field, and the timing of this asset sale is virtually perfectly meshed with the Company’s plans for growth.

Following the recent acquisition of PoViva Tea; the Belmont Lake oilfield asset sale; and the retirement of all corporate debt, Lexaria expects to retain a cash balance of approximately US$1 million. Lexaria has no plans for any corporate financing at this time.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Tags: , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Enters Agreement to Sell Belmont Lake Oil Assets

INTERVIEW: Supreme (SL:CSE) Discusses Construction Progress at 342,000 SQF. Medical Marijuana Production Facility

Posted by AGORACOM-JC at 8:22 PM on Tuesday, November 25th, 2014

Supreme Discusses Progress of 342K sqf. Medical Marijuana Production Facility

WATCH INTERVIEW NOW!

  • Significant progress made at its 342,000 square foot greenhouse facility located in Kincardine, Ontario
  • Moving quickly to implement its proposed plan to produce up to 24,000,000 grams of medical marijuana
  • Recently completed $1.7M financing
  • Received conditional pre-approval letter from Health Canada

Supreme is a Canadian-owned and operated company whose mission is to enhance the quality of life for their patients and clients by producing sun-grown medical marijuana of the highest standards, quality and value. The company’s vision is a client-centered, environmentally-friendly and affordable medical marijuana marketplace sustained by the marriage of commercial agriculture and traditional growing.

Hub On AGORACOM / Corporate Profile / Watch Interview!

Tags: , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Supreme Pharmaceuticals Inc | Comments Off on INTERVIEW: Supreme (SL:CSE) Discusses Construction Progress at 342,000 SQF. Medical Marijuana Production Facility

Lexaria Develops Proprietary Cannabidiol Technology

Posted by AGORACOM-JC at 10:10 AM on Monday, November 24th, 2014

VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) — A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy.

Dr. Devinsky administered cannabidiol to 23 patients with treatment-resistant epilepsy. Thirty-nine percent of the patients saw their seizure rates drop by more than 50%. Four patients (17%) had no seizures for the last month of treatment.

Lexaria (CSE:LXX) (OTCQB:LXRP) has acquired 51% of PoViva Corp, an innovative health company developing Cannabidiol (CBD)-infused products. Lexaria may increase its ownership position to 75% at a later date.

“Most CBD’s taste awful,” stated Lexaria CEO and Chairman Chris Bunka in an exclusive interview with Financial Press. “Marian Washington and Michelle Reillo – the two principals at PoViva – have developed patent-pending technology to bind CBD to a lipid. As well as enabling the body to process the CBDs more efficiently, this technology makes it taste much better.”

The first PoViva Tea by Lexaria will be a traditional black tea, which accounts for about 85% of all the tea consumed. Initially Lexaria will sell the CBD lipid-bound tea loosely – and then as the product line gets traction Bunka anticipates introducing flavored teas and tea bags.

In March, 2014 Lexaria entered into the medical marijuana market in Canada where it is legal federally. Its production license application is being reviewed by Health Canada.

“We continue to press for that license,” stated Bunka. “But we made an executive and board decision to build immediate value for the company pursuing opportunities in the hemp-based Cannabidiol (CBD) market – which does not require new licensing, laws or legislation.”

The Alternative Health sector is growing fast. A six year survey with 29,370 subjects monitored the adoption of “complementary and alternative medicine care professionals,” including “homeopathic, naturopathic, or herbalists.”

The study suggests that between 16.9 million and 18.5 million Americans are seeking an alternative health care professional at any given time.

“The US Department of Health has patented CBDs and claimed that they are beneficial in treating Parkinson’s, Alzheimer’s, Cancer, Cardio-vascular diseases and concussion,” stated Bunka. “An overwhelming body of research indicates that Cannabidiol has significant medicinal properties.”

Bunka sees Cannabidiol products as much more than a niche health market. There are many patients with Alzheimer’s and other diseases who don’t want to use marijuana.

Lexaria is planning to market its products to the 150 million daily tea drinkers in the United States. The market for CBDs is much larger than that of marijuana-users.

“We’re not changing focus, we’re sharpening it,” stated Bunka. “We are still in the same sector, but in a 100% legal part of it, which means we can produce foods that contain CBD and create short term cash flows for the company.”

Lexaria is in the process of launching a new e-commerce website and setting up a national distribution center, with 1-800 call ordering.

“Our marketing will include traditional media, direct marketing, and we also are building relationships with alternative health media outlets,” stated Bunka. “Some of these organizations have expressed interest in affiliate marketing campaigns so we are also exploring that.”

Bunka has a conservative approach to alternative medicine, including cannabis. The company has initiated a Responsible Marijuana Policy which states that Lexaria will not sell medical marijuana containing more than 0.3% THC to any medical marijuana patient under the age of 25.

Subsequent to Lexaria’s announcement, the College of Family Physicians of Canada created new guidelines that included the recommendation that medical marijuana in most cases would not be appropriate for patients under the age of 25.

Lexaria is currently investigating several popular food and drink sectors where its patent-pending lipid-binding Cannabidiol delivery system might prove effective. Lexaria has acquired a 3-year exclusive right to the patent-pending process to infuse CBD’s into all global markets outside of the USA.

The 2015 combined hot beverage markets of coffee and tea together, globally, is expected to be $69 Billion according to a report by Basu Majumder A., Bera B. and Rajan A.

According to the US Department of Health and Human Services Patent number 6,630,507, “Cannabidiol is particularly advantageous to use because it avoids toxicity that is encountered with psychoactive cannabinoids at high doses.”

Lexaria continues to pursue the Health Canada MMPR Licensed Producer status by way of its joint venture in Burlington Ontario with Enertopia Corp. Meanwhile Bunka is focussed on producing cash flows from new initiatives; including the CBD-sectors (like epilepsy treatment) derived from already-legal hemp.

According to the Center for Disease Control and Prevention, Epilepsy affects about 2 million people in the United States and accounts for $15.5 billion in direct costs and indirect costs.

Lexaria is currently trading at .09 with a market capitalisation of $3.1 million.

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

CONTACT: Lexaria Corp.
         950 - 1130 West Pender Street Vancouver BC V6E 4A4
         p. 604 602 1675 f. 604 685 1602
         e. [email protected]
Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Develops Proprietary Cannabidiol Technology

Cannabis (MMJ) Goes Mainstream

Posted by AGORACOM-JC at 4:46 PM on Friday, November 21st, 2014

Vancouver, BC / November 24, 2014 / 3,500 well-dressed investors and entrepreneurs converged last week in Las Vegas in what was the marijuana industry’s biggest event to date by far – the 3rd annual Marijuana Business Conference and Expo.

It was a monumental event, bringing together some of the top agricultural companies in the country with experts in security, logistics, software, packaging, even Wall St. was there as well as several reported celebrity sightings. To say we have a very hot new sector in this country is an understatement.

Supreme Pharmaceuticals (SL-CSE) (SPRWF-OTC) is looking like a champion on this frontier, having built a high-tech pharmaceutical-grade greenhouse in Canada, ideally suited for cannabis cultivation on a large-scale.

“In May 2014 we purchased a 342,000 square foot agricultural greenhouse in Kincardine, Ontario,” stated Supremes’ Director of Operations in an exclusive interview with Financial Press, “since then we’ve deployed over $4 million dollars to convert it into a medical marijuana growing facility that exceeds the federal regulatory requirements.”

The speedy execution of the construction phase reflects the financial, entrepreneurial and operational mix of Supremes’ management team. The company has a solid track record in capital markets, logistics and the marijuana space.

In January, 2014 Supreme received a “Ready-to-Build” letter from the federal regulator indicating its proposal to produce up to 24,000 KG of medical marijuana per year met the regulatory requirements. The ready to build letter states that a producer’s license will be issued following a successful pre-licence inspection.

As the pre-license construction phase comes to a close, the company is now one step away from a green light to commercially produce medical marijuana. “Within the next few weeks we anticipate completing all of the pre-installed regulatory requirements” stated Fowler, “that means the security infrastructure, quality assurance and record keeping protocols are all in place – and we’re ready to put seeds in the ground and turn the lights on.”

Fowler describes the Kincardine greenhouse as the ideal facility to produce high quality, low cost medical marijuana, which will become one of Supremes’ cornerstone competitive advantages. In addition to the traditional cost-saving benefits of greenhouse agriculture, this greenhouse is uniquely suited to medical marijuana production. “The greenhouse is designed to be much shorter than a traditional agricultural greenhouse,” Fowler continued, “which is ideal for shorter plants like marijuana. This design means there are millions of cubic feet of air that we do not have to manage with our climate control systems. Reducing heating and cooling saves costs and boosts production efficiency.”

The size of the Kincardine facility gives Supreme a significant competitive advantage over other applicants. Health Canada’s regulatory guidance states that it intends to transform a sprawling cottage industry to a small number of scaled growing facilities. “Economies-of-scale have enabled us to make significant capital expenses with construction and quality control” said Fowler, “we’re doing premium installations that would not be practical for a 40,000 square foot facility.”

Supreme is also one of the first medical marijuana companies to take an agricultural approach to the production of medical marijuana. “This is an agricultural business first, which is why we are utilizing an agricultural facility and the latest technology for automated greenhouse agriculture” stated Fowler, “we have a large, secured, highly automated facility capable of providing a sustainable supply of a standardized medical product, something the medical community has told us is essential. One of the problems with smaller facilities is that they can run out of product, depending on the harvesting cycle. That can be a problem for patients who are only responsive to one strain. Supremes’ scale means that we can guarantee reliability and consistency in the supply chain.”

Fowler describes the biggest advantage Supreme gains from the greenhouse is the town of Kincardine itself. “The unforeseen benefit of this greenhouse facility in Kincardine had been the town itself,” stated Fowler, “We’ve got support from all levels of government, the local business community and the residents. Last Saturday we had a job fair, which was attended by over 600 locals, even though we only advertised twenty positions. That level of support is unprecedented in an industry where simply being left alone is a victory.”

Image: http://www.accesswire.com/images/322/Untitled.jpg

Fowler has been involved in the medical marijuana industry for over a decade. He’s likely the only businessman and corporate lawyer in Canada who also has extensive hands-on experience with the medical marijuana patient community and marketplace.

Fowler also intends to use his experience as a patient advocate to help Supreme attract patients who require medical marijuana to treat various ailments. “We are going to institute innovating pricing models,” stated Fowler, “designed to accommodate patients on a limited budget and mitigate the fact insurance providers do not yet cover medical marijuana.”

On November 17, 2014 Supreme closed a non-brokered private placement financing which, based on investor interest, was increased in size twice, generating $1.78 million in additional capital for the Company.

Supreme Pharmaceuticals is currently trading on the Canadian Securities Exchange at $.41 with a market cap of $31 million.

Financial Press Legal Disclaimer/Disclosure to go at end of each client article:

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

Contact Information

Investor Relations
430-580 Hornby Street, Vancouver BC
V6C 3B6 Phone: (604) 674-2191
Email:[email protected]
Website: www.supreme.com

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Medical Marijuana Stocks, Supreme Pharmaceuticals Inc | Comments Off on Cannabis (MMJ) Goes Mainstream

Enertopia Provides Footage of Planned MMPR Facility

Posted by AGORACOM-JC at 9:59 AM on Thursday, November 20th, 2014

Whitefish, MT / November 20, 2014 / Thus far there has only been a handful of companies approved by Health Canada for the MMPR program, including Tweed Inc. (TSX-V: TWD) and Organigram Inc. (TSX-V: OGI), while a number of other companies, such as Abattis Bioceuticals (OTC: ATTBF) continue to await their approvals from Health Canada.

While many publicly traded companies have been talking up their plans of becoming licensed producers, few have been very open about showing off their actual facilities and demonstrating how operations will work. Outdoor images of large warehouses and pictures of land from a mile high provide investors with very little information about what’s actually happening in these companies.

Enertopia Corp. (OTC: ENRT) recently released a four part video series in conjunction with its joint venture with The Green Canvas Ltd. After signing a joint venture agreement in February of 2014, the company has begun building and outfitting a 30,000 square foot facility – scalable to 55,000 square feet – to become compliant with Health Canada’s MMPR standards.

The video tour of the planned facility includes everything from the initial clone rooms, perimeter security, vegetative grow areas, vaults, multiple staging areas for flowering, and the lights that will be used for production.

In the overall 4 part video series, Enertopia’s management team discusses its operational plans within Canada’s rapidly growing medical marijuana industry, while also interviewing current medical marijuana patients that have been treated with the utmost compassion by Green Canvas. The Green Canvas’ history as a licensed producer under the legacy Medical Marijuana Access Regulations (“MMAR”) program also provides them with the ability to show actual current growing operations.

It is the expertise of these current operations that deserves special notice. On November 8th, 2014 the invite only Karma Cup was held to determine the best flowering varieties of marijuana for the indica, sativa, and hybrid entrants. With more than 70 entrants, the Green Canvas was awarded first place in the sativa category for their Ambrosia strain. This year the Green Canvas was also awarded first place in the Sativa category at the Prairie Medicinal Harvest Cup for the 4th year in a row, achievements that the company is very proud of since the sativa strains typically take much longer to grow, and are often times more effective at treating the medical conditions of their patients.

As well, in September the Green Canvas joint venture announced that it submitted its application to become a licensed producer, and that they are in correspondence with Health Canada regarding specific quality assurance reports. Facility upgrades are ongoing and the construction progress can be seen in the aforementioned videos, highlighting just how close the company is to bringing the planned facility to fruition.

Tim Selenski is the head grower for the Green Canvas Ltd. grow team, and has worked with the Canadian government via their MMAR program for over 10 year time. Since its involvement in the MMAR program, Green Canvas has been widely covered in the Canadian media and has become a trusted source for medical marijuana patients.

Click For More Information:

– Company Website – http://www.enertopia.com/

– CannabisFN Profile Page – http://www.cannabisfn.com/mdc/enertopia-corp/

Legal Disclaimer:

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Tags: , , , ,
Posted in Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Provides Footage of Planned MMPR Facility

« Older Entries
Newer Entries »